Meiotic recombination observed through preimplantation genetic testing for two X-linked conditions: first reported case in humans.
5 affiliations
- 1Division of Medical Genetics, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
- 2Perinatal Genetics, Stanford Medicine Children's Health, Stanford, California.
- 3Masters Program in Human Genetics and Genetic Counseling, Department of Genetics, Stanford University, Stanford, California.
- 4Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Stanford University, Stanford, California.
- 5Department of Pathology, Stanford University School of Medicine, Stanford, California.
Abstract
Objective
To report a case of human meiotic recombination illustrated by the use of preimplantation genetic testing for monogenic disorders (PGT-M) in a female patient heterozygous for pathogenic variants in cis on the X chromosome, highlighting the potential implications of meiotic recombination when performing PGT-M for ≥2 variants located on the same chromosome of a parental haplotype.Design
Case report.Subjects
A G3P3 female patient, heterozygous for two X-linked pathogenic variants in cis, involving the OTC and STS genes, sought to conceive an unaffected pregnancy through the use of in vitro fertilization (IVF) with PGT-M on the basis of her history of having a son with ornithine transcarbamylase (OTC) deficiency and steroid sulfatase (STS) deficiency who died following a hyperammonemic crisis.Exposure
Preimplantation genetic testing for monogenic disorders for maternal OTC and STS variants, previously determined to be in cis in the patient and her deceased son.Main outcome measures
Proportion of embryos that screened positive by PGT-M for both, neither, or only one of the maternal OTC and STS variants.Results
Preimplantation genetic testing for monogenic disorders was performed on 13 embryos. Nine (69%) embryos screened positive for both or neither of the maternal OTC (c.788A>G) and STS (1.6Mb deletion of Xp22.31) variants, as expected given their configuration in cis. Four embryos (31%) screened positive for only one variant (either the OTC or STS variant), suggestive of X-linked meiotic recombination occurring at the frequency predicted on the basis of the genomic distance between STS and OTC. The patient transferred a female euploid embryo low-risk by PGT-M for the maternal OTC and STS variants, and declined prenatal diagnostic testing via chorionic villus sampling or amniocentesis. The patient delivered a healthy term female infant via repeat Cesarean section.Conclusion
Meiotic recombination may lead to unanticipated results when using PGT-M to screen embryos for multiple monogenic conditions involving variants on the same chromosome. Detection of linked variants when screening embryos for genetic conditions (i.e., instead of direct genotyping) could lead to a false-negative result. This case underscores the importance of involving medical geneticists and genetic counselors to facilitate comprehensive and accurate clinical genetic evaluations, variant interpretation, confirmatory testing, and risk assessment to promote informed reproductive decision-making.
Related
- Exposure to point-of-sale tobacco advertising and children’s observed and reported interest in tobacco advertising: a cross-sectional study in Japan
- A method for measuring neighborhood conditions across the life course using self-reported addresses
- A community survey of reported deaths and perceived disability associated with potentially untreated surgical conditions in a rural–urban population in Lagos, Nigeria: a SOSAS survey
- Use of patient-reported outcome measures for upper limb musculoskeletal conditions among physiotherapists in Tamil Nadu, India: a mixed-methods study
- Self-reported functional and mobility limitations in mid-life: a systematic review of prevalence and association with chronic health conditions
BibTeX
@article{iversen2026meiotic,
title = {{Meiotic recombination observed through preimplantation genetic testing for two X-linked conditions: first reported case in humans.}},
author = {Anna Iversen and Sara K Gerber and Solmaz Chamanara and Kajal Verma and Sophia M Adelson and Cindy Yang and Christina G Tise},
journal = {F\&S reports},
year = {2026},
month = aug,
doi = {10.1016/j.xfre.2026.08.001},
url = {https://europepmc.org/article/MED/42903386},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Meiotic recombination observed through preimplantation genetic testing for two X-linked conditions: first reported case in humans.
AU - Anna Iversen
AU - Sara K Gerber
AU - Solmaz Chamanara
AU - Kajal Verma
AU - Sophia M Adelson
AU - Cindy Yang
AU - Christina G Tise
PY - 2026
DA - 2026/08/11
JO - F&S reports
DO - 10.1016/j.xfre.2026.08.001
UR - https://europepmc.org/article/MED/42903386
AB - Objective To report a case of human meiotic recombination illustrated by the use of preimplantation genetic testing for monogenic disorders (PGT-M) in a female patient heterozygous for pathogenic variants in cis on the X chromosome, highlighting the potential implications of meiotic recombination when performing PGT-M for ≥2 variants located on the same chromosome of a parental haplotype.Design Case report.Subjects A G3P3 female patient, heterozygous for two X-linked pathogenic variants in cis, involving the OTC and STS genes, sought to conceive an unaffected pregnancy through the use of in vitro fertilization (IVF) with PGT-M on the basis of her history of having a son with ornithine transcarbamylase (OTC) deficiency and steroid sulfatase (STS) deficiency who died following a hyperammonemic crisis.Exposure Preimplantation genetic testing for monogenic disorders for maternal OTC and STS variants, previously determined to be in cis in the patient and her deceased son.Main outcome measures Proportion of embryos that screened positive by PGT-M for both, neither, or only one of the maternal OTC and STS variants.Results Preimplantation genetic testing for monogenic disorders was performed on 13 embryos. Nine (69%) embryos screened positive for both or neither of the maternal OTC (c.788A>G) and STS (1.6Mb deletion of Xp22.31) variants, as expected given their configuration in cis. Four embryos (31%) screened positive for only one variant (either the OTC or STS variant), suggestive of X-linked meiotic recombination occurring at the frequency predicted on the basis of the genomic distance between STS and OTC. The patient transferred a female euploid embryo low-risk by PGT-M for the maternal OTC and STS variants, and declined prenatal diagnostic testing via chorionic villus sampling or amniocentesis. The patient delivered a healthy term female infant via repeat Cesarean section.Conclusion Meiotic recombination may lead to unanticipated results when using PGT-M to screen embryos for multiple monogenic conditions involving variants on the same chromosome. Detection of linked variants when screening embryos for genetic conditions (i.e., instead of direct genotyping) could lead to a false-negative result. This case underscores the importance of involving medical geneticists and genetic counselors to facilitate comprehensive and accurate clinical genetic evaluations, variant interpretation, confirmatory testing, and risk assessment to promote informed reproductive decision-making.
SN - 2666-3341
ER -